Stay updated with breaking news from Davidm Nathan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The process of blood glucose control could improve dramatically with a bionic pancreas, according to a new study. Currently, people with type 1 diabetes maintain a constant vigil because their pancreas doesn't make the hormone insulin and so they need to manually insure that blood glucose levels don't get dangerously high and low.
UAB researchers say the presented data indicates that a younger age and higher HbA1c at baseline predict early treatment failure and point to the need for more aggressive initial treatment in these patients. University o...
With nearly 40 million Americans having diabetes, new treatments for the chronic disease continue to be developed.
Two diabetes research giants, Ralph DeFronzo, MD, and David Nathan, MD, faced off on whether to use initial combination therapy versus starting with metformin and adding more medications sequentially.
The Diabetes Control and Complications Trial (DCCT) and its follow-on observational study EDIC continue to provide new insights into type 1 diabetes as the study participants age.